rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2002-9-4
|
pubmed:abstractText |
Unmethylated cytosine-phosphate-guanine (CpG) oligodeoxynucleotides are highly frequent motifs in bacterial DNA and rare in the mammalian genome. They are potent inducers of inflammatory cytokines and act synergistically with lipopolysaccharide (LPS) for the induction of tumor necrosis factor alpha (TNF-alpha) production in vivo. It has therefore been suggested that innate immune reaction to bacterial unmethylated CpG motifs might contribute to the development of septic shock. We designed this study to assess the sensitization role of CpG motifs in LPS-induced shock using the D-galactosamine (D-GalN)-sensitized mouse model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0342-4642
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1340-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12209287-Animals,
pubmed-meshheading:12209287-Base Sequence,
pubmed-meshheading:12209287-CpG Islands,
pubmed-meshheading:12209287-DNA Primers,
pubmed-meshheading:12209287-Lipopolysaccharides,
pubmed-meshheading:12209287-Mice,
pubmed-meshheading:12209287-Mice, Inbred BALB C,
pubmed-meshheading:12209287-Models, Biological,
pubmed-meshheading:12209287-Pentoxifylline,
pubmed-meshheading:12209287-Prospective Studies,
pubmed-meshheading:12209287-RNA, Messenger,
pubmed-meshheading:12209287-Shock, Septic,
pubmed-meshheading:12209287-Thionucleotides,
pubmed-meshheading:12209287-Tumor Necrosis Factor-alpha
|
pubmed:year |
2002
|
pubmed:articleTitle |
Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model.
|
pubmed:affiliation |
Unité INSERM U547, Institut Pasteur de Lille, 59019 Lille Cedex, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|